<?xml version="1.0" encoding="UTF-8"?>
<!-- XBRL document created with Ez-XBRL version 4.0.0.7 [05/06/2012 07:19:24 PM] -->
<!-- Based on XBRL 2.1  -->
<!--XBRL Document Modified with Ez-Viewer Version 1.0.4.1 on Monday, May 07, 2012 08:40:33 AM -->
<xbrli:xbrl xmlns:bcli="http://www.brainstorm-cell.com/20120331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2011-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink">
	<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="bcli-20120331.xsd"/>
	<!-- Context Section  -->
	<xbrli:context id="Context_6ME_31-Mar-2001">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2001-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2001-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2001-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2001-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2001-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2002">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2001-04-01
</xbrli:startDate>
			<xbrli:endDate>
2002-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2001-04-01
</xbrli:startDate>
			<xbrli:endDate>
2002-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2001-04-01
</xbrli:startDate>
			<xbrli:endDate>
2002-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2001-04-01
</xbrli:startDate>
			<xbrli:endDate>
2002-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2001-04-01
</xbrli:startDate>
			<xbrli:endDate>
2002-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2003">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2002-04-01
</xbrli:startDate>
			<xbrli:endDate>
2003-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2002-04-01
</xbrli:startDate>
			<xbrli:endDate>
2003-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2002-04-01
</xbrli:startDate>
			<xbrli:endDate>
2003-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2002-04-01
</xbrli:startDate>
			<xbrli:endDate>
2003-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2002-04-01
</xbrli:startDate>
			<xbrli:endDate>
2003-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2004">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2003-04-01
</xbrli:startDate>
			<xbrli:endDate>
2004-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2003-04-01
</xbrli:startDate>
			<xbrli:endDate>
2004-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2003-04-01
</xbrli:startDate>
			<xbrli:endDate>
2004-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2003-04-01
</xbrli:startDate>
			<xbrli:endDate>
2004-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2003-04-01
</xbrli:startDate>
			<xbrli:endDate>
2004-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2005">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2004-04-01
</xbrli:startDate>
			<xbrli:endDate>
2005-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2004-04-01
</xbrli:startDate>
			<xbrli:endDate>
2005-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2004-04-01
</xbrli:startDate>
			<xbrli:endDate>
2005-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2004-04-01
</xbrli:startDate>
			<xbrli:endDate>
2005-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2004-04-01
</xbrli:startDate>
			<xbrli:endDate>
2005-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2006">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2005-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2005-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2005-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2005-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2005-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_9ME_31-Dec-2006">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2006-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2006-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2006-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2006-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2006-04-01
</xbrli:startDate>
			<xbrli:endDate>
2006-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2007">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2007-01-01
</xbrli:startDate>
			<xbrli:endDate>
2007-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2007-01-01
</xbrli:startDate>
			<xbrli:endDate>
2007-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2007-01-01
</xbrli:startDate>
			<xbrli:endDate>
2007-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2007-01-01
</xbrli:startDate>
			<xbrli:endDate>
2007-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2007-01-01
</xbrli:startDate>
			<xbrli:endDate>
2007-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2008">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2008-01-01
</xbrli:startDate>
			<xbrli:endDate>
2008-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2008-01-01
</xbrli:startDate>
			<xbrli:endDate>
2008-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2008-01-01
</xbrli:startDate>
			<xbrli:endDate>
2008-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2008-01-01
</xbrli:startDate>
			<xbrli:endDate>
2008-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2008-01-01
</xbrli:startDate>
			<xbrli:endDate>
2008-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2009">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2009-01-01
</xbrli:startDate>
			<xbrli:endDate>
2009-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2009-01-01
</xbrli:startDate>
			<xbrli:endDate>
2009-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2009-01-01
</xbrli:startDate>
			<xbrli:endDate>
2009-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2009-01-01
</xbrli:startDate>
			<xbrli:endDate>
2009-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2009-01-01
</xbrli:startDate>
			<xbrli:endDate>
2009-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2010">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2010-01-01
</xbrli:startDate>
			<xbrli:endDate>
2010-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2010-01-01
</xbrli:startDate>
			<xbrli:endDate>
2010-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2010-01-01
</xbrli:startDate>
			<xbrli:endDate>
2010-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2010-01-01
</xbrli:startDate>
			<xbrli:endDate>
2010-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2010-01-01
</xbrli:startDate>
			<xbrli:endDate>
2010-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2011">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2011">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2011-01-01
</xbrli:startDate>
			<xbrli:endDate>
2011-12-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2011">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2012">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2012-01-01
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2012-01-01
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2012-01-01
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2012-01-01
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2012-01-01
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2012">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2012-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2012-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2012-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2012-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2012-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_Custom_31-Mar-2012">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>
2000-09-23
</xbrli:startDate>
			<xbrli:endDate>
2012-03-31
</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_22-Sep-2000">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-22
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2001">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2001-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-22
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2001-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-22
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2001-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-22
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2001-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-22
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2001-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2002">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2002-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2002-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2002-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2002-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2002-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2003">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2003-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2003-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2003-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2003-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2003-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2004">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2004-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2004-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2004-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2004-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2004-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2005">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2005-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2005-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2005-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2005-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2005-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2006">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2006">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2006-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2007">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2007-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2007-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2007-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2007-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2007-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2008">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2008-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2008-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2008-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2008-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2008-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2009">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2009-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2009-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2009-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2009-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2009-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2010">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2010-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2010-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2010-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2010-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2010-12-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2011">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bcli:DeficitAccumulatedDuringTheDevelopmentStageMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2011-03-31
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="Context_As_Of_21-Sep-2000">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>
2000-09-21
</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<!-- Unit Section  -->
	<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
	<xbrli:unit id="USDPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
	<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
	<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_3ME_31-Mar-2012">BRAINSTORM CELL THERAPEUTICS INC</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef="Context_3ME_31-Mar-2012">0001137883</dei:EntityCentralIndexKey>
	<dei:CurrentFiscalYearEndDate contextRef="Context_3ME_31-Mar-2012">--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityFilerCategory contextRef="Context_3ME_31-Mar-2012">Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:TradingSymbol contextRef="Context_3ME_31-Mar-2012">bcli</dei:TradingSymbol>
	<dei:DocumentType contextRef="Context_3ME_31-Mar-2012">10-Q</dei:DocumentType>
	<dei:AmendmentFlag contextRef="Context_3ME_31-Mar-2012">false</dei:AmendmentFlag>
	<dei:DocumentPeriodEndDate contextRef="Context_3ME_31-Mar-2012">2012-03-31</dei:DocumentPeriodEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="Context_3ME_31-Mar-2012">Q1</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="Context_3ME_31-Mar-2012">2012</dei:DocumentFiscalYearFocus>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1923000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_1">1145000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_22-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="-3">1000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="-3">93000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-Mar-2011" unitRef="USD" decimals="-3">3664000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_21-Sep-2000" unitRef="USD" decimals="-3" id="Item_3">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">312000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">482000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">69000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">148000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:AssetsCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">2304000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">1775000</us-gaap:AssetsCurrent>
	<us-gaap:PrepaidExpenseNoncurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">17000</us-gaap:PrepaidExpenseNoncurrent>
	<us-gaap:PrepaidExpenseNoncurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">17000</us-gaap:PrepaidExpenseNoncurrent>
	<bcli:SeverancePayFund contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">109000</bcli:SeverancePayFund>
	<bcli:SeverancePayFund contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">129000</bcli:SeverancePayFund>
	<us-gaap:LongTermInvestments contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">126000</us-gaap:LongTermInvestments>
	<us-gaap:LongTermInvestments contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">146000</us-gaap:LongTermInvestments>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">314000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">328000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:Assets contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">2744000</us-gaap:Assets>
	<us-gaap:Assets contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">2249000</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">244000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">325000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">750000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">839000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccountsPayableOtherCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">141000</us-gaap:AccountsPayableOtherCurrent>
	<us-gaap:AccountsPayableOtherCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">126000</us-gaap:AccountsPayableOtherCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1135000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">1290000</us-gaap:LiabilitiesCurrent>
	<us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">121000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
	<us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">142000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
	<us-gaap:Liabilities contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1256000</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">1432000</us-gaap:Liabilities>
	<us-gaap:CommonStockValue contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">6000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">6000</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">45560000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">45761000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">44078000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
	<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">44950000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">1488000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">6000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">45560000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-44078000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">817000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">6000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">45761000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-44950000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001" unitRef="USD" decimals="-3">68000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">84000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-17000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002" unitRef="USD" decimals="-3">53000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">95000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-43000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003" unitRef="USD" decimals="-3">21000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">110000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-90000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004" unitRef="USD" decimals="-3">-31000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">131000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-163000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005" unitRef="USD" decimals="-3">704000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">25101000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-5395000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-19003000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006" unitRef="USD" decimals="-3">-7911000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15803000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-1395000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-22320000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006" unitRef="USD" decimals="-3">-1816000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">24427000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-26244000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007" unitRef="USD" decimals="-3">-2428000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">2000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">30058000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-32488000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008" unitRef="USD" decimals="-3">-2076000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">3000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">33881000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-35960000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009" unitRef="USD" decimals="-3">-1743000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">4000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">35994000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-37741000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010" unitRef="USD" decimals="-3">-459000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">5000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">39696000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-40160000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2011" unitRef="USD" decimals="-3">2666000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">6000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">43525000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-40865000</us-gaap:StockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" decimals="-3">2744000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" decimals="-3">2249000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Dec-2011" unitRef="USDPerShare" decimals="5">0.00005</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31-Mar-2012" unitRef="USDPerShare" decimals="5">0.00005</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31-Dec-2011" unitRef="Shares" decimals="0">800000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31-Mar-2012" unitRef="Shares" decimals="0">800000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31-Dec-2011" unitRef="Shares" decimals="0">126444309</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31-Mar-2012" unitRef="Shares" decimals="0">126737158</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31-Dec-2011" unitRef="Shares" decimals="0">126444309</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31-Mar-2012" unitRef="Shares" decimals="0">126737158</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">270000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">369000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_4">24788000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">258000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">510000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_6">17513000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:OperatingExpenses contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">528000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">879000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_7">42301000</us-gaap:OperatingExpenses>
	<us-gaap:InterestExpense contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-177000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">11000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_8">-2536000</us-gaap:InterestExpense>
	<us-gaap:OtherNonoperatingIncome contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OtherNonoperatingIncome contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OtherNonoperatingIncome contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_9">-132000</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">705000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">868000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_10">44705000</us-gaap:OperatingIncomeLoss>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-4000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_11">-81000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">705000</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">872000</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromContinuingOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_12">44786000</us-gaap:IncomeLossFromContinuingOperations>
	<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
	<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
	<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_13">164000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
	<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">-17000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-17000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002" unitRef="USD" decimals="-3">-26000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-26000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003" unitRef="USD" decimals="-3">-47000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-47000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">-73000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-73000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">-18840000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-18840000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">-3317000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-3317000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">-3924000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-3924000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">-6244000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-6244000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">-3472000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-3472000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">-1781000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-1781000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">-2419000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-2419000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-705000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-705000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">-3918000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-3918000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-872000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">-872000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_14">-44950000</us-gaap:NetIncomeLoss>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="Context_3ME_31-Mar-2011" unitRef="USDPerShare" decimals="2">0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="Context_3ME_31-Mar-2012" unitRef="USDPerShare" decimals="2">0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
	<bcli:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_31-Mar-2011" unitRef="Shares" decimals="0">108895199</bcli:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<bcli:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME_31-Mar-2012" unitRef="Shares" decimals="0">126591262</bcli:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">126444309</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">126737158</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_22-Sep-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">0</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10100000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10100000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10100000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10238000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">20867808</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">22854587</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">24201812</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">41004409</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">55241418</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">76309152</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">95832978</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">121034291</us-gaap:SharesOutstanding>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">17506000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_15">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">17506000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">662000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_17">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">662000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">453000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">453000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">1446000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1446000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">33000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">33000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">775000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_18">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">775000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">96000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_19">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">96000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-20000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-20000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">449000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">449000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">4000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">4000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">2025000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">934904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1147225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">544095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">5284284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">443333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">474203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">5979000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-5979000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_20">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">486000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">-486000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">1168000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_21">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1168000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">1232000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_22">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1232000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">731000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">731000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">409000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">409000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">388000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_23">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">388000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">27000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">27000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">1135000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1135000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">177000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">177000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsValue>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">200000</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">466667</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares>
	<bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">2025040</bcli:StockBasedCompensationRelatedToOptionsGrantedToEmployeesAndDirectorsShares>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_24">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">137000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">137000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">140000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">140000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">402385</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">445617</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">755594</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleNote>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_25">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_26">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">55000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">55000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">243000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">243000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">17399</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1540885</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">94764</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1648728</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">167849</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">214000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_27">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">214000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_28">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_29">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">11000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_30">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">272000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">272000</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_31">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3" id="Item_32">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">3832621</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1860000</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">3366783</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">3929446</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1046834</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="Context_3ME_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">125000</bcli:StockIssuedDuringPeriodSharesExerciseOfWarrants>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">3602000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3601000</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValue contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValue>
	<bcli:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">14160933</bcli:StockIssuedDuringPeriodSharesPrivatePlacement>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_33">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">24000</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValuePreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">2000001</bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10499999</bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares contextRef="Context_FYE_31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10499999</bcli:StockIssuedDuringPeriodSharesPreviouslySubscribedShares>
	<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">17000</bcli:StockIssuedDuringPeriodForCashInSeptember>
	<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForCashInSeptember>
	<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">16000</bcli:StockIssuedDuringPeriodForCashInSeptember>
	<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInSeptember>
	<bcli:StockIssuedDuringPeriodForCashInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInSeptember>
	<bcli:StockIssuedDuringPeriodForCashSharesInSeptember contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">8500000</bcli:StockIssuedDuringPeriodForCashSharesInSeptember>
	<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForCashInMarch>
	<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_34">0</bcli:StockIssuedDuringPeriodForCashInMarch>
	<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForCashInMarch>
	<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInMarch>
	<bcli:StockIssuedDuringPeriodForCashInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForCashInMarch>
	<bcli:StockIssuedDuringPeriodForCashSharesInMarch contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1600000</bcli:StockIssuedDuringPeriodForCashSharesInMarch>
	<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
	<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_35">0</bcli:StockIssuedDuringPeriodValueStockSplits>
	<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
	<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
	<bcli:StockIssuedDuringPeriodValueStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueStockSplits>
	<us-gaap:StockIssuedDuringPeriodSharesStockSplits contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">10100000</us-gaap:StockIssuedDuringPeriodSharesStockSplits>
	<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">6000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
	<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_36">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
	<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">6000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
	<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
	<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
	<us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">100000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_37">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3" id="Item_38">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_39">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodValue contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockCancelledDuringPeriodValue>
	<bcli:StockCancelledDuringPeriodShares contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">-10062000</bcli:StockCancelledDuringPeriodShares>
	<bcli:StockCancelledDuringPeriodShares contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">-1800000</bcli:StockCancelledDuringPeriodShares>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_40">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">60000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJune contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">8510000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJune>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001" unitRef="USD" decimals="-3">8000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">8000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_6ME_31-Mar-2001_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2002_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2003_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_41">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2004_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">7000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">7000</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalContributionOfCapital>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">1418000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_42">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1418000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">2000000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1999000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">1500000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1499000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">1751000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1750000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">250000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">250000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1894808</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">11500000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">8625000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">9916667</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">7250000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">833333</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesOne>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">584000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">584000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2005_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">1174000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">51000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">1123000</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AmortizationOfDeferredStockBasedCompensationRelatedToSharesAndOptionsGrantedToEmployeesAndDirectors>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">149000</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_43">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">149000</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInMay contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">186875</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInMay>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">99000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_44">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">99000</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJuly contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">165000</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInJuly>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">225000</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_45">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">225000</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInSeptember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">312500</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInSeptember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_46">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">135000</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInDecember contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">187500</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesInDecember>
	<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
	<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
	<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-3363000</bcli:ForfeitureOfOptionsGrantedToEmployees>
	<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">3363000</bcli:ForfeitureOfOptionsGrantedToEmployees>
	<bcli:ForfeitureOfOptionsGrantedToEmployees contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:ForfeitureOfOptionsGrantedToEmployees>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">-7906000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-7906000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">7191000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">7191000</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalReclassificationDueToApplication>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006" unitRef="USD" decimals="-3">164000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">164000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Mar-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">1086000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1086000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">407000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">407000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
	<bcli:EliminationOfDeferredStockCompensaitonDueToImplementation contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensaitonDueToImplementation>
	<bcli:EliminationOfDeferredStockCompensaitonDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensaitonDueToImplementation>
	<bcli:EliminationOfDeferredStockCompensaitonDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">-1395000</bcli:EliminationOfDeferredStockCompensaitonDueToImplementation>
	<bcli:EliminationOfDeferredStockCompensaitonDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">1395000</bcli:EliminationOfDeferredStockCompensaitonDueToImplementation>
	<bcli:EliminationOfDeferredStockCompensaitonDueToImplementation contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:EliminationOfDeferredStockCompensaitonDueToImplementation>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">109000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">109000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToConvertibleNoteHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006" unitRef="USD" decimals="-3">110000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">110000</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
	<bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder contextRef="Context_9ME_31-Dec-2006_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalWarrantIssuedToLoanHolder>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007" unitRef="USD" decimals="-3">224000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_47">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">224000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">1276000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_48">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1276000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">200000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_49">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">200000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">189000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3" id="Item_50">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">189000</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodValueConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">725881</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">3644610</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">2500000</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
	<bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">1016109</bcli:StockIssuedDuringPeriodSharesConversionOfConvertibleLoans>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">2475000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">201000</us-gaap:DebtConversionConvertedInstrumentAmount1>
	<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">201000</us-gaap:DebtConversionConvertedInstrumentAmount1>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008" unitRef="USD" decimals="-3">281000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">281000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2008_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009" unitRef="USD" decimals="-3">729000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">729000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2009_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010" unitRef="USD" decimals="-3">455000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">455000</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement contextRef="Context_FYE_31-Dec-2010_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:AdjustmentsToAdditionalPaidInCapitalSubscriptionOfSharesForPrivatePlacement>
	<bcli:StockIssuedDuringPeriodForCashInSeptemberPricePerShare contextRef="Context_6ME_31-Mar-2001" unitRef="USDPerShare" decimals="5">0.00188</bcli:StockIssuedDuringPeriodForCashInSeptemberPricePerShare>
	<bcli:StockIssuedDuringPeriodForCashInMarchPricePerShare contextRef="Context_6ME_31-Mar-2001" unitRef="USDPerShare" decimals="4">0.0375</bcli:StockIssuedDuringPeriodForCashInMarchPricePerShare>
	<bcli:PricePerShareOfStockIssuedDuringPeriodToPurchaseMineralOption contextRef="Context_FYE_31-Mar-2004" unitRef="USDPerShare" decimals="3">0.065</bcli:PricePerShareOfStockIssuedDuringPeriodToPurchaseMineralOption>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJune contextRef="Context_FYE_31-Mar-2005" unitRef="USDPerShare" decimals="2">0.01</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJune>
	<bcli:StockIssuedExpenses contextRef="Context_FYE_31-Mar-2005" unitRef="USD" decimals="-3">25000000</bcli:StockIssuedExpenses>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Mar-2005" unitRef="USDPerShare" decimals="2">0.75</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Dec-2007" unitRef="USDPerShare" decimals="4">0.1818</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne contextRef="Context_FYE_31-Dec-2008" unitRef="USDPerShare" decimals="4">0.1818</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementIssueOne>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInMay contextRef="Context_FYE_31-Mar-2006" unitRef="USDPerShare" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInMay>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJuly contextRef="Context_FYE_31-Mar-2006" unitRef="USDPerShare" decimals="2">0.60</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInJuly>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInSeptember contextRef="Context_FYE_31-Mar-2006" unitRef="USDPerShare" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInSeptember>
	<bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInDecember contextRef="Context_FYE_31-Mar-2006" unitRef="USDPerShare" decimals="2">0.80</bcli:PricePerShareOfStockIssuedDuringPeriodForPrivatePlacementInDecember>
	<bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement contextRef="Context_FYE_31-Dec-2008" unitRef="USDPerShare" decimals="4">0.1818</bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement>
	<bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement contextRef="Context_FYE_31-Dec-2010" unitRef="USDPerShare" decimals="2">0.12</bcli:PricePerShareOfSubscriptionOfSharesDuringPeriodForPrivatePlacement>
	<us-gaap:OtherDepreciationAndAmortization contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">38000</us-gaap:OtherDepreciationAndAmortization>
	<us-gaap:OtherDepreciationAndAmortization contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">38000</us-gaap:OtherDepreciationAndAmortization>
	<us-gaap:OtherDepreciationAndAmortization contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_51">1039000</us-gaap:OtherDepreciationAndAmortization>
	<us-gaap:SeveranceCosts contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-8000</us-gaap:SeveranceCosts>
	<us-gaap:SeveranceCosts contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">1000</us-gaap:SeveranceCosts>
	<us-gaap:SeveranceCosts contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_52">13000</us-gaap:SeveranceCosts>
	<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
	<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInInterestPayableNet>
	<us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_53">451000</us-gaap:IncreaseDecreaseInInterestPayableNet>
	<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_54">1864000</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
	<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
	<us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_55">795000</us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments>
	<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-20000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
	<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">4000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
	<bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_56">21490000</bcli:ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders>
	<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">27000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">177000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_57">6998000</us-gaap:ShareBasedCompensation>
	<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-265000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
	<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">249000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
	<bcli:IncreaseInAccountsReceivableAndPrepaidExpenses contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_58">630000</bcli:IncreaseInAccountsReceivableAndPrepaidExpenses>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">94000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">81000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_59">798000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">254000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">74000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_60">1471000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
	<bcli:ErosionOfRestrictedCash contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</bcli:ErosionOfRestrictedCash>
	<bcli:ErosionOfRestrictedCash contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:ErosionOfRestrictedCash>
	<bcli:ErosionOfRestrictedCash contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_61">6000</bcli:ErosionOfRestrictedCash>
	<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-55000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-746000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_62">-12093000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
	<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_63">-23000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-55000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-746000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_64">-12116000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">37000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">52000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_65">1185000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInRestrictedCash>
	<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInRestrictedCash>
	<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_66">-6000</us-gaap:IncreaseDecreaseInRestrictedCash>
	<bcli:InvestmentInLeaseDeposit contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">1000</bcli:InvestmentInLeaseDeposit>
	<bcli:InvestmentInLeaseDeposit contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:InvestmentInLeaseDeposit>
	<bcli:InvestmentInLeaseDeposit contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_67">-17000</bcli:InvestmentInLeaseDeposit>
	<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-36000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-52000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_68">-1196000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
	<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_69">-16000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">-36000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-52000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_70">-1212000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">3607000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_71">12319000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_72">2061000</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
	<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">55000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
	<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
	<us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_73">651000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
	<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:RepaymentsOfOtherShortTermDebt>
	<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:RepaymentsOfOtherShortTermDebt>
	<us-gaap:RepaymentsOfOtherShortTermDebt contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_74">601000</us-gaap:RepaymentsOfOtherShortTermDebt>
	<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">3662000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_75">14430000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
	<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
	<us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_76">43000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">3662000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">20000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_77">14473000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">3571000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">-778000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_Custom_31-Mar-2012" unitRef="USD" decimals="-3" id="Item_78">1145000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<bcli:ConversionOfTradePayableToCommonStock contextRef="Context_3ME_31-Mar-2011" unitRef="USD" xsi:nil="true"/>
	<bcli:ConversionOfTradePayableToCommonStock contextRef="Context_3ME_31-Mar-2012" unitRef="USD" xsi:nil="true"/>
	<bcli:ConversionOfOtherAccountsPayableToCommonStock contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">24000</bcli:ConversionOfOtherAccountsPayableToCommonStock>
	<bcli:ConversionOfOtherAccountsPayableToCommonStock contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:ConversionOfOtherAccountsPayableToCommonStock>
	<bcli:ConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">137000</bcli:ConversionOfConvertibleNote>
	<bcli:ConversionOfConvertibleNote contextRef="Context_3ME_31-Mar-2012" unitRef="USD" decimals="-3">0</bcli:ConversionOfConvertibleNote>
	<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0%;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 1&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;GENERAL&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;A.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Brainstorm Cell Therapeutics Inc. (formerly: Golden Hand Resources Inc.) (the "Company") was incorporated in the State of Washington on September 22, 2000.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;B.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On May 21, 2004, the former major stockholders of the Company entered into a purchase agreement with a group of private investors, who purchased from the former major stockholders 6,880,000 shares of the then issued and outstanding 10,238,000 shares of Common Stock.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;C.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On July 8, 2004, the Company entered into a licensing agreement with Ramot of Tel Aviv University Ltd. ("Ramot"), to acquire certain stem cell technology (see Note 4). Subsequent to this agreement, the Company decided to focus on the development of novel cell therapies for neurodegenerative diseases based on the acquired technology and research to be conducted and funded by the Company.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;Following the licensing agreement dated July 8, 2004, the management of the Company decided to abandon all old activities related to the sale of the digital data recorder product. The discontinuation of this activity was accounted for under the provision of Statement of Financial Accounting Standard ASC 360-10 (formerly "SFAS" 144), "Accounting for the Impairment or Disposal of Long-Lived Assets".&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 84.45pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;D.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On October 25, 2004, the Company formed a wholly-owned subsidiary in Israel, Brainstorm Cell Therapeutics Ltd. ("BCT").&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;E.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On November 22, 2004, the Company changed its name from Golden Hand Resources Inc. to Brainstorm Cell Therapeutics Inc. to better reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. BCT, as defined below, owns all operational property and equipment.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;F.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On September 17, 2006, the Company changed the Company's fiscal year-end from March 31 to December 31. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;G.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In December 2006, the Company changed its state of incorporation from Washington to Delaware. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;H.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Since its inception, the Company has devoted substantially all of its efforts to research and development, recruiting management and technical staff, acquiring assets and raising capital. In addition, the Company has not generated revenues. Accordingly, the Company is considered to be in the development stage, as defined in Statement of Financial
 Accounting Standards No. 7, "Accounting and reporting by development Stage Enterprises" ASC 915-10 (formerly "SFAS No.&amp;#160;7").&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;I.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In October 2010, the Israeli Ministry of Health (&amp;#8220;MOH&amp;#8221;) granted clearance for a Phase I/II clinical trial using the Company&amp;#8217;s autologous NurOwn&amp;#8482; stem cell therapy in patients with amyotrophic lateral sclerosis&lt;/font&gt; (&amp;#8220;&lt;font style="font-weight: normal;"&gt;ALS&amp;#8221;), subject to some additional process specifications as well as completion of the sterility validation study for tests performed. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On February 23, 2011, the Company submitted to the MOH all the required documents. Following approval of the MOH, a Phase I/II clinical study for ALS patients using the Company&amp;#8217;s autologous NurOwn&amp;#8482; stem cell therapy (the &amp;#8220;Clinical Trial&amp;#8221;) was initiated in June 2011. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In January 2012, the Company reported on an interim safety follow-up of the first 4 patients enrolled in its Clinical Trial indicating that no significant treatment-related adverse events were reported. The NurOwn&amp;#8482; treatment has thus so far proven to be safe, and has shown some initial indications of beneficial clinical effects.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 28.35pt;"&gt;&lt;b&gt;J&lt;/b&gt;.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;In February 2011, the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) granted orphan drug designation to the Company&amp;#8217;s NurOwn&amp;#8482; autologous adult stem cell product candidate for the treatment of ALS.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: left; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;b&gt;GOING CONCERN &lt;/b&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;As reflected in the accompanying financial statements, the Company&amp;#8217;s operations for the three months ended March 31, 2012, resulted in a net loss of $872. The Company&amp;#8217;s balance sheet reflects an accumulated deficit of $44,950. These conditions, together with the fact that the Company is a development stage Company and has no revenues nor are revenues expected in the near future, raise substantial doubt about the Company's ability to continue to operate as a going concern. The Company&amp;#8217;s ability to continue operating as a &amp;#8220;going concern&amp;#8221; is dependent on several factors, among them is its ability to raise sufficient additional working capital.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;In 2009, the Company decided to focus only on the effort to commence clinical trials for ALS and such trials did commence in 2011.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;In February 2011, the Company raised approximately $3.8 million from institutional and private investors. However, there can be no assurance that additional funds will be available on terms acceptable to the Company, or at all.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 58.5pt; font: 10pt times new roman, times, serif;"&gt;These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
	<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE&amp;#160;2&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2011 are applied consistently in these financial statements.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
	<bcli:ResearchAndLicenseAgreementTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0%;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE&amp;#160;4&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;RESEARCH AND LICENSE AGREEMENT&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;The Company has a Research and License Agreement, as amended and restated, with Ramot. The Company obtained a waiver and release from Ramot pursuant to which Ramot agreed to an amended payment schedule regarding the Company's payment obligations under the Research and License Agreement and waived all claims against the Company resulting from the Company's previous defaults and non-payment under the Research and License Agreement. The waiver and release amended and restated the original payment schedule under the original agreement providing for payments during the initial research period and additional payments for any extended research period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;As of December 24, 2009, the Company had paid to Ramot $400 but did not make payments totaling $240 for the initial research period and payments totaling $380 for the extended research period. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On December 24, 2009, the Company and Ramot entered into a settlement agreement which amended the Research and License Agreement, as amended and restated pursuant to which, among other things, the following matters were agreed upon:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Ramot released the Company from its obligation to fund the extended research period in the total amount of $1,140. Therefore, the Company deleted an amount in 2009, equal to $760 from it research and development expenses that were previously expensed.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;b)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;Past due amounts of $240 for the initial research period plus interest of $32 owed by the Company to Ramot was converted into 1,120,000 shares of common stock on December 30, 2009. Ramot was required to deposit the shares with a broker and only sell the shares in the open market after 185 days from the issuance date.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;c)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In the event that the total proceeds generated by sales of the shares on December 31, 2010, together with the March 31, 2010 payment, are less than $240 on or prior to December 31, 2010, then on such date the Company shall pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240. Related compensation in the amount of $51 was recorded as research and development expenses.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In January 2011 Ramot exercised additional 167,530 Common Stock of the Company, for $35, which finalized the sale of the 1,120,000 Common Stock of the Company granted to Ramot for $235. In February 2011 the Company paid the remaining $5 and finalized the balance due to Ramot according to the settlement agreement between the parties dated December 24, 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</bcli:ResearchAndLicenseAgreementTextBlock>
	<bcli:ConsultingAgreementsTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE&amp;#160;5&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;CONSULTING AGREEMENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;A.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On July 8, 2004, the Company entered into two consulting agreements with Prof. Eldad Melamed and Dr. Daniel Offen (together, the "Consultants"), under which the Consultants provide the Company scientific and medical consulting services in consideration for a monthly payment of $6 each. In addition, the Company granted each of the Consultants, a fully vested warrant to purchase 1,097,215 shares of Common Stock at an exercise price of $0.01 per share. The warrants issued pursuant to the agreement were issued to the Consultants effective as of November 4, 2004. Each of the warrants is exercisable for a seven-year period beginning on November 4, 2005. As of September 2010, all the above warrants had been exercised.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;On December 16, 2010, the Company approved a grant of 1,100,000 shares of the Company's Common Stock to the two Consultants, for services rendered through December 31, 2010. Related compensation in the amount of $220 was recorded as research and development expense. A sum of $487 was cancelled concurrently with the issuance of the 1,100,000 shares of Common Stock of the Company.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -27pt; margin: 0pt 0px 0pt 85.5pt; font: 10pt times new roman, times, serif;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 27pt;"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On June 27, 2011, the Company approved an additional grant of 400,000&lt;/font&gt; &lt;font style="font-weight: normal;"&gt;shares of the Company's Common Stock to Prof. Daniel Offen, for services rendered through December 31, 2009. Related compensation in the amount of $192 is recorded as research and development expense.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;D.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;As of March 31, 2012, the Company has a total obligation of $135 for services rendered by the Consultants under the abovementioned agreements. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: left; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</bcli:ConsultingAgreementsTextBlock>
	<bcli:ShortTermConvertibleNoteTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;&lt;b&gt;NOTE 6&amp;#160;&amp;#160;&amp;#160;-&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;b&gt;SHORT-TERM CONVERTIBLE NOTE&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;On December 13, 2009, the Company issued a $135 Convertible Promissory Note to its legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the Note accrued at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;The gap between the amount the Company owed to the legal advisor and the principal of the Convertible Promissory Note in the amount of $82 was deducted from general and administrative expenses.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;On February 19, 2010, the Company's legal advisor converted the entire accrued principal and interest of $135 Convertible Promissory Note into 402,385 shares of Common Stock.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;On September 15, 2010, the Company issued a $135 Convertible Promissory Note to its legal advisor for legal fees accrued through December 31, 2010. Interest on the Note was at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;On February 18, 2011, the legal advisor converted the entire accrued principal and interest into 445,617 shares of Common Stock.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</bcli:ShortTermConvertibleNoteTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 8&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;STOCK CAPITAL&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27.75pt;"&gt;A.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;The rights of Common Stock are as follows:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 84.45pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;Holders of Common Stock have the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company and the right to receive dividends, if declared.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;The Common Stock is registered and publicly traded on the Over-the-Counter Bulletin Board service of the National Association of Securities Dealers, Inc. under the symbol BCLI.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 56.7pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;B.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Issuance of shares warrants and options:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 85.05pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;1.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Private placements:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;a)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On June 24, 2004, the Company issued to investors 8,510,000 shares of Common Stock for total proceeds of $60 (net of $25 issuance expenses).&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;b)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On February 23, 2005, the Company completed a private placement for sale of 1,894,808 units for total proceeds of $1,418. Each unit consists of one share of Common Stock and a three-year warrant to purchase one share of Common Stock at $2.50 per share. This private placement was consummated in three tranches which closed in October 2004, November 2004 and February 2005.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;c)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On May 12, 2005, the Company issued to an investor 186,875 shares of Common Stock at a price of $0.8 per share for total proceeds of $149.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;d)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On July 27, 2005, the Company issued to investors 165,000 shares of Common Stock at a price of $0.6 per share for total proceeds of $99.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;e)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On August 11, 2005, the Company signed a private placement agreement with investors for the sale of up to 1,250,000 units at a price of $0.8 per unit. Each unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock at $1.00 per share. The warrants are exercisable for a period of three years from issuance. On March 31, 2005, the Company sold 312,500 units for total net proceeds of $225. On December 7, 2005, the Company sold 187,500 units for total net proceeds of $135.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;f)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On July 2, 2007, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to
 27,500,000 shares of Common Stock, for an aggregate subscription price of up to $5 million and warrants to purchase up to 30,250,000 shares of Common Stock. Separate closings of the purchase and sale of the shares and the warrants were originally scheduled to take place as follows:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 170.1pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; text-indent: 0px; padding-left: 0px; font-weight: bold;"&gt;Purchase&amp;#160;date&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Purchase&amp;#160;price&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Number&amp;#160;of &lt;br /&gt;subscription &lt;br /&gt;shares&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Number&amp;#160;of &lt;br /&gt;warrant &lt;br /&gt;shares&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px; width: 41%; vertical-align: top;"&gt;August 30, 2007&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%; vertical-align: top;"&gt;$&lt;/td&gt;
&lt;td style="text-align: center; width: 20%;"&gt;1,250 (includes $250 paid as a convertible loan)&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 15%;"&gt;6,875,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 15%;"&gt;7,562,500&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;November 15, 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right;"&gt;750&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;February 15, 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right;"&gt;750&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;May 15, 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right;"&gt;750&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;July 30, 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right;"&gt;750&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; text-indent: 0px; padding-left: 0px;"&gt;November 15, 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right;"&gt;750&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 18, 2009, the Company entered into an amendment to the investment agreement with the investor providing for the following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;(a)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;The investor shall invest the remaining amount of the original investment agreement at price per share of $0.12 in monthly installments of not less than $50 starting August 1, 2009. The investor may accelerate such payments at his discretion.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in;
 margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;(b)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;The exercise price of the last 10,083,334 warrants decreased from an exercise price of $0.36 per share to $0.29 per share. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;(c)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;All warrants expire on November 5, 2013 instead of November 5, 2011.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;(d)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;The price per share of the investment agreement decreased from $0.1818 to $0.12, therefore the Company adjusted the number of Shares of Common Stock issuable pursuant the investment agreement retroactively and issued to the investor on October 28, 2009 an additional 9,916,667 shares of Common Stock for past investment.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;font style="font-weight: normal;"&gt;(e)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;The investor has the right to cease payments in the event that the price per share as of the closing on five consecutive trading days shall decrease to $0.05.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On January 18, 2011 the Company and an investor signed an agreement to balance amounts due to the investor, totaling $20, against the remaining balance of the investment. The Company issued to the investor 10,499,999 shares of Common Stock and a warrant to purchase 4,539,500 shares of the Company's Common Stock at an exercise price of $0.20 per share&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;As of March 31, 2011, the Company issued to the investor and its designees an aggregate of 41,666,667 shares of common stock and a warrant to purchase 10,083,333 shares of the Company's common stock at an exercise price of $0.20 per share and a warrant to purchase 20,166,667 shares of common stock at an exercise price of $0.29 per share. The warrants may be exercised at any time and expire on November 5, 2013. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In addition, the Company agreed to issue an aggregate of 1,250,000 shares of Common Stock to a related party as an introduction fee for the investment. The shares shall be issued pro rata to the funds received from the investor.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;As of December 31, 2010, the introduction fee was paid in full.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 115.65pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;g)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;In January 2010, the Company issued 1,250,000 units to a private investor for total proceeds of $250. Each unit consists of one share of Common Stock and a two-year warrant to purchase one share of Common Stock at $0.50 per share. &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;h)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font: 10pt times new roman, times, serif;"&gt;In February 2010, the Company issued 6,000,000 shares of Common Stock to 3 investors (2,000,000 to each investor) and warrants to purchase an aggregate of 3,000,000 shares of Common Stock (1,000,000 to each investor) with an exercise price of $0.5 for aggregate proceeds of $1,500 ($500 each).&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font
 style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;i)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On February 7, 2011, the Company issued 833,333 shares of Common Stock, at a price of $0.3 per share, and a warrant to purchase 641,026 shares of the Company's Common Stock at an exercise price of $0.39 per share for one year for total proceeds of $250.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: -28.35pt; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;j)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-weight: normal;"&gt;On February 23, 2011, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to 12,815,000 shares of Common Stock, for an aggregate subscription price of up to $3.6 million and warrants to purchase up to 19,222,500 shares of Common Stock as follows: warrant to purchase 12,815,000 shares of Common Stock at $0.5 for two years, and warrants to purchase 6,407,500 shares of Common Stock at $0.28 for one year.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In addition, the Company agreed to pay 10% of the funds received for the distribution services received, out of this amount, 4% was be paid in stock and the remaining 6% in cash. Accordingly, in March 2011, the company issued 512,600 Common Stock and paid $231.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;2.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Share-based compensation to employees and to directors:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;a)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Options to employees and directors:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On November 25, 2004, the Company's stockholders approved the 2004 Global Stock Option Plan and the Israeli Appendix thereto (which applies solely to participants who are residents of Israel) and on March 28, 2005, the Company's stockholders approved the 2005 U.S. Stock Option and Incentive Plan, and the reservation of 9,143,462 shares of Common Stock for issuance in the aggregate under these stock option plans.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;Each option granted under the plans is exercisable until the earlier of ten years from the date of grant of the option or the expiration dates of the respective option plans. The 2004 and 2005 options plans will expire on November 25, 2014 and March 28, 2015, respectively. The exercise price of the options granted under the plans may not be less than the nominal value of the shares into which such options are exercised. The options vest primarily over three or four years. Any options that are canceled or forfeited before expiration become available for future grants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 5, 2008, the Company's stockholders approved an amendment and restatement of&amp;#160;the Company&amp;#8217;s 2004 Global Share Option Plan and 2005 U.S. Stock Option and Incentive Plan to increase the number of shares of common stock available for issuance under these stock option plans in the aggregate by 5,000,000 shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In June 2011, the Company's stockholders approved an increase the number of shares of common stock available for issuance under these stock option plans in the aggregate by 5,000,000 shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;As of March 31, 2012, 1,825,103 options are available for future grants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 27, 2005, the Company granted one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.75 per share. The option is fully vested and expires after 10 years.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in;
 margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On February 6, 2006, the Company entered into an amendment to the Company's option agreement with the Company's former Chief Financial Officer. The amendment changed the exercise price of the 400,000 options granted to him on February 13, 2005 from $0.75 to $0.15 per share. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 2, 2006, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and expires after 10 years. The compensation related to the option, in the amount of $48, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 22, 2006, the Company entered into an amendment to the Company's option agreement with two of its employees. The amendment changed the exercise price of 270,000 options granted to them from $0.75 to $0.15 per share. The excess of the fair value resulting from the modification, in the amount of $2, was recorded as general and administration expense over the remaining vesting period of the options.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On September 17, 2006, the Company entered into an amendment to the Company's option agreement with one of its directors. The amendment changed the exercise price of 100,000 options granted to the director from $0.75 to $0.15 per share.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On March 21, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $43, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On July 1, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $38, was recorded as general and administrative expense. On October 22, 2007, the Company and the director agreed to cancel and relinquish all the options which were granted on July 1, 2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On July 16, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $75, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 27, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $84, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On October 23, 2007, the Company granted to its Chief Executive Officer an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.87 per share. The option is fully vested and expires after 10 years. The total compensation related to the option is $733, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On November 5, 2008, the Company entered into an amendment to the Company's option agreement with the Company's Chief Executive Officer. The amendment changed the exercise price of the 1,000,000 options from $0.87 to $0.15 per share. The compensation related the modification of the purchase price in the amount of $4 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight:
 normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 29, 2009, the Company granted to its former Chief Executive Officer and director an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.067 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $68, which is amortized over the vesting period as general and administrative expense. In February 2011, the former CEO resigned. On July 25, 2011 the Company signed a settlement agreement with the former CEO under which 483,333 shares out of the above grant became fully vested exercisable through April 30 2012. An additional $30 was written as compensation in general and administrative expense. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;After the balance sheet date, the former CEO exercised the option to 483,333 shares of Common Stock for an exercise price of $32.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;"&gt;On June 29, 2009, the Company granted to its former Chief Financial Officer an option to purchase 200,000 shares of Common Stock at an exercise price of $0.067 per share. The option vested with respect to 1/3 of the shares subject to the option. In connection with the former Chief Financial Officer&amp;#8217;s resignation,&lt;/font&gt; &lt;font style="font-family: times new roman, times, serif;"&gt;2/3 of the above shares were cancelled and the remaining 66,667 are valid through April 7, 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 31, 2009, the Company granted to two of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. Each option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $32, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On December 13, 2009, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $21, was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On February 10, 2010, the Company granted to an employee an option to purchase 30,000 shares of Common Stock at an exercise price of $0.32 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $9, which is amortized over the vesting period as research and development expense. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 13, 2010, the Company, Abraham Israeli and Hadasit Medical Research Services and Development Ltd. (&amp;#8220;Hadasit&amp;#8221;) entered into an Agreement (the &amp;#8220;Agreement&amp;#8221;) pursuant to which Mr. Israeli agreed, during the term of the Agreement, to serve as (i) the Company&amp;#8217;s Clinical Trials Advisor and (ii) a member of the Company&amp;#8217;s Board of Directors.&amp;#160;&amp;#160;In consideration of the services to be provided by Mr. Israeli to the Company under the Agreement, the Company agreed to grant options annually during the term of the Agreement for the purchase of its Common Stock, as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="width: 0.25in;"&gt;&lt;font style="font-family: symbol; font-weight: normal;"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;"&gt;An option for the purchase of 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share to Mr. Israeli; and&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="width: 0.25in;"&gt;&lt;font style="font-family: symbol; font-weight: normal;"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-family: times new roman, times, serif; font-weight: normal;"&gt;An option for the purchase of 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share to Hadasit,&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td
 style="width: 141.75pt;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 0.25in;"&gt;&lt;font style="font-family: symbol; font-weight: normal;"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;font style="font-family: times new roman, times, serif;"&gt;*&amp;#160;&amp;#160;&amp;#160;&amp;#160;Such options will vest and become exercisable in twelve (12) consecutive equal monthly amounts.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In April 2010, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option was $50, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On January 30, 2011 the Company signed an agreement with a new COO and acting CEO. According to the employment agreement, the new COO received 450,000 options to purchase Common Stock of the Company at $0.20.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 27 2011, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option was $48, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 27 2011, the Company granted to four of its directors an option to purchase 634,999 shares of Common Stock of the Company at $0.15. The total compensation related to the option was $287, which is amortized over the vesting period as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 10 2011, the Company granted to its CEO, an option to purchase 70,000 shares of Common Stock of the Company at $0.20. The total compensation related to the option was $26, which was amortized as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;In the three months ended March 31 2012, 167,849 options were exercised by former CEO of the Company for $20.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;After the balance sheet date, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share.&lt;/p&gt;
&lt;p style="text-align: left; margin: 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;A summary of the Company's option activity related to options to employees and directors, and related information is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="10"&gt;For&amp;#160;the&amp;#160;period&amp;#160;ended &lt;br /&gt;March&amp;#160;31,&amp;#160;2012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Amount &lt;br /&gt;of &lt;br /&gt;options&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Weighted &lt;br /&gt;average &lt;br /&gt;exercise &lt;br /&gt;price&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2"&gt;Aggregate &lt;br /&gt;intrinsic &lt;br /&gt;value&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;"&gt;$&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;"&gt;$&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white;
 vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 41%;"&gt;Outstanding at beginning of period&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 20%;"&gt;4,938,821&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 15%;"&gt;0.168&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 15%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;Granted&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;Exercised&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;167,849&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.150&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Reclassified&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;13,784&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 1pt;"&gt;0.067&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Outstanding at end of period&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;4,784,756&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;0.169&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;807,430&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Vested and expected-to-vest at end of period&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;3,784,617&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;0.166&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;627,162&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 2, 2006, the Company issued to two of its directors 200,000 restricted shares of common stock (100,000 each). The restrictions on the shares have fully lapsed. The compensation related to the stocks issued amounted to $104, which was amortized over the vesting period as general and administrative expenses.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font
 style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to a director 100,000 restricted shares of Common Stock. The restrictions on the shares have fully lapsed. The compensation related to the shares issued amounted to $47, which was amortized over the vesting period as general and administrative expenses.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In addition, on April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to another director 100,000 restricted shares of Common Stock. The restricted shares are not subject to any right to repurchase, and the compensation related to the shares issued amounted to $47 was recorded as prepaid general and administrative expenses in the three months ended March 31, 2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 27, 2008, the Company issued to one of its directors 960,000 shares of Common Stock upon a cashless exercise by a shareholder of a warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $.01 per share that was acquired by the shareholder from Ramot. The shares were allocated to the director by the shareholder.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In May 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its directors 300,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In May and in June 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its Scientific Advisory Board members and two of its Advisory Board members 500,000 restricted shares of common stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 6, 2010, Prof. Melamed fully exercised his warrant to purchase 1,097,215 shares of the Company&amp;#8217;s Common Stock; the warrant was issued to him pursuant to the agreement with the Consultants effective as of November 4, 2004. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 85.05pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;3.&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Shares and warrants to investors and service providers:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;The Company accounts for shares and warrants issued to non-employees using the guidance of ASC 718-10 (formerly "SFAS" 123(R)), "Accounting for Stock-Based Compensation" and ASC 505-50-30 (formerly "EITF" 96-18), "Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling, Goods or Services," whereby the fair value of such option and warrant grants is determined using a Black-Scholes options pricing model at the earlier of the date at which the non-employee's performance is completed or a performance commitment is reached.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 0px;"&gt;&lt;/td&gt;
&lt;td style="width: 28.35pt;"&gt;&lt;b&gt;a)&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;&lt;b&gt;Warrants to investors and service providers and investors: &lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="width: 100%; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left; font-weight: bold;" nowrap="nowrap"&gt;Issuance&amp;#160;date&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Number&amp;#160;of &lt;br /&gt;warrants &lt;br /&gt;issued&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Exercised&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Forfeited&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"
 nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Exercise &lt;br /&gt;Price&amp;#160;$&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Warrants &lt;br /&gt;exercisable&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Exercisable&amp;#160;through&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 37%;"&gt;November 2004&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;12,800,845&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;11,761,281&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;151,803&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;887,761&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;0.01&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;887,761&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 6%;"&gt;April 2012&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;December 2004&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,800,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,800,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.00005&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#8211;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,894,808&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,894,808&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2.5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;47,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;47,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1.62&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;June 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;30,000&lt;/td&gt;
&lt;td style="text-align:
 left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;30,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.75&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;30,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;June 2015&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;August 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;70,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;70,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;September 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;September 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;36,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;36,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.75&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;September-December 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;December 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;20,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;20,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;December 2005&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;457,163&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;150,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align:
 left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;307,163&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;307,163&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;December 2015&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;230,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;230,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.65&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;230,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;February 2016&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;40,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;40,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1.5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;8,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;8,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;189,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;97,696&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;91,304&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0. 5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.0005&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;May 2016&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May -December 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;48,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;48,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.35&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May -December 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;48,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;48,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.75&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;May 2011&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;June 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;24,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;24,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;19,355&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;19,355&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;October 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;630,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;630,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.3&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;December 2006&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align:
 left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.47&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.47&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;March 2017&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;15,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;15,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;225,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;225,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;March 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;50,000&lt;/td&gt;
&lt;td style="text-align:
 left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;April 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,300&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,300&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;May 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;250,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;250,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;July 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.39&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;July 2017&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;September 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;August 2017&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;August 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;7,562,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;7,562,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.2&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;7,562,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;July 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;30,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;30,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;July 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.45&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;October 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" nowrap="nowrap"&gt;August-October&amp;#160;2017&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;November 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,520,833&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,520,833&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.20&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,520,833&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;November 2007&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,016,667&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,016,667&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;2,016,667&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;April 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;August 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,529,166&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,529,166&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,529,166&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td
 style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;August 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,008,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,008,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,008,333&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;November 2008&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.15&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;September 2018&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;April 2009&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.1&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;April 2019&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;October 2009&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;200,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;100,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.067&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;66,667&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;October 2019&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;October 2009&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;January 2010&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,250,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,250,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2010&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align:
 right;"&gt;125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;125,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.01&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2010&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,000,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;3,000,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;January 2011&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.29&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;4,537,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;November 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2011&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;641,026&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;641,026&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.39&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2011&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;6,407,500&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;946,834&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;5,460,666&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.28&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2011&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;12,815,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;12,815,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.5&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;12,815,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;February 2013&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;April 2010&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;0.00005&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;April 2020&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;April 2011&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;33,334&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;April 2021&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;February 2010&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;1,500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;500,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;February 2020&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;78,604,165&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;15,633,811&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;14,533,762&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;48,436,590&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;47,403,257&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;The fair value for the warrants to service providers was estimated on the date of grant using a Black-Scholes option pricing model, with the following weighted-average assumptions for the 3 month activity ended on March 31, 2011; weighted average volatility of 134%-141%, risk free interest rates of 2.26%-3.47% dividend yields of 0% and a weighted average life of the options of 6-10 years. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 113.4pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 113.4pt;"&gt;&lt;/td&gt;
&lt;td style="width: 28.5pt;"&gt;b)&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;Shares:&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 1 and June 4, 2004, the Company issued 40,000 and 150,000 shares of Common Stock for 12 months of filing services and legal and due-diligence services, respectively, with respect to a private placement. Compensation expense related to filing services, totaling $26, was amortized over a 12-month period. Compensation related to legal services, totaling $105 was recorded as equity issuance cost and had no effect on the statement of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent:
 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On July 1 and September 22, 2004, the Company issued 20,000 and 15,000 shares to a former director for financial services for the first and second quarters of 2004, respectively. Related compensation in the amount of $39 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On February 10, 2005, the Company signed an agreement with one of its service providers under which the Company issued the service provider 100,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In March and April 2005, the Company signed an agreement with four members of its Scientific Advisory Board under which the Company issued to the members of the Scientific Advisory Board 400,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan (100,000 each). All restrictions on these shares have lapsed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In July 2005, the Company issued to its legal advisors 50,000 shares for legal services for 12 months. The compensation related to the shares in the amount of $37.5 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;In January 2006, the Company issued to two service providers 350,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed. Related compensation in the amount of $23 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On March 6, 2006, the Company issued to its legal advisor 34,904 shares of Common Stock. The shares are in lieu of $18.5 payable to the legal advisor. Related compensation in the amount of $18.5 was recorded as general and administrative expense. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 13, 2006, the Company issued to service providers 60,000 shares of Common Stock at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. Related compensation in the amount of $25.8 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 9, 2006, the Company issued to its legal advisor 65,374 shares of Common Stock in lieu of payment for legal services. Related compensation in the amount of $33 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On June 7, 2006, the Company issued to a service provider 50,000 shares of Common Stock for filing services for 12 months. Related compensation in the amount of $24.5 was recorded as general and administrative expense. &lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 5, 2006, the Company issued 200,000 shares of Common Stock to a finance consultant for his services. Related compensation in the amount of $102 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 14, 2006, the Company issued 200,000 shares of Common Stock to a service provider. Related compensation in the amount of $68 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On August 17, 2006, the Company issued 100,000 shares of Common Stock to a service provider. Related compensation in the amount of $35 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify;
 text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On September 17, 2006, the Company issued to its legal advisor 231,851 shares of Common Stock in lieu of $63 payable to the legal advisor. [Related compensation in the amount of $63 was recorded as general and administrative expense.]&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 1 and September 30, 2006, the Company issued to its business development advisor, based on an agreement, 240,000 shares of Common Stock. Related compensation in the amount of $74 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On January 3, 2007, the Company issued to its legal advisor 176,327 shares of Common Stock in lieu of $45 payable to the legal advisor. Related compensation in the amount of $49 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 12, 2007, the Company issued to its filing and printing service providers 80,000 shares of Common Stock in lieu of $15 payable to the service provider. Related compensation in the amount of $30 was recorded as general and administrative expense. In addition, the Company was obligated to issue the filing and printing service providers additional shares, in the event that the total value of the shares previously issued (as quoted on the Over-the-Counter Bulletin Board or such other exchange where the Common Stock is quoted or listed) was less than $0.20 on March 20, 2008. As a result, the Company recorded a liability in the amount of $20.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On April 12, 2007, the Company issued to its legal advisor 108,511 shares of Common Stock in lieu of $29 payable to the legal advisor. Related compensation in the amount of $40 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On May 18, 2007, the Company issued to its legal advisor 99,257 shares of Common Stock in lieu of $33 payable to the legal advisor. Related compensation in the amount of $33 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On October 29, 2007, the Company issued to a scientific advisory board member 80,000 shares of the Company&amp;#8217;s Common Stock for scientific services. Compensation of $67 was recorded as research and development expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On May 20, 2008, the Company issued to its financial advisor 90,000 shares of the Company's Common Stock. The shares were for $35 payable to the financial advisor for introduction fee of past convertible loans. Related compensation in the amount of $36 was recorded as financial expenses.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On April 5, 2009, the Company issued to its Chief Technology Advisor 1,800,000 shares of Common Stock. The shares were for $180 payable to the advisor. Related compensation in the amount of $144 was recorded as research and development expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On June 24, 2009, the Company issued to its public relations advisor 250,000 shares of Common Stock. The shares were for $25 payable to the advisor. Related compensation in the amount of $18 was recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On July 8, 2009, the Company issued to its financial consultant 285,714 shares of the Company's Common Stock. The shares were for $20 payable to the financial consultant for valuation of options and warrants. Related compensation in the amount of $20 was recorded as general and administrative expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On July 15, 2009, the Company issued to a service provider 357,142 shares of the Company's Common Stock. The shares were for $25 payable to the service provider for filing services. Related compensation in the amount of $21 was recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt
 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On August 10, 2009, the Company issued to a service provider 71,428 shares of the Company's Common Stock. The shares were for $5 payable to the service provider for IT services. Related compensation in the amount of $4 was recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On January 5, 2010, the Company issued to its public relations advisor 50,000 shares of the Company's Common Stock for six months service. The issuance of the shares is part of the agreement with the public relations advisor that entitled them to a monthly grant of 8,333 shares of the Company's Common Stock. Related compensation in the amount of $12 was recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 143pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On January 6, 2010, the Company issued to a service provider 60,000 shares of the Company's Common Stock. The shares were for $15 payable to the service provider for insurance and risk management consulting and agency services for three years. Related compensation in the amount of $16 was recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On March 5, 2007, the Company issued a $150 Convertible Promissory Note to a third party. Interest on the note accrued at the rate of 8% per annum for the first year and 10% per annum after the first year. On January 27, 2010, the third party converted the entire accrued principle and interest outstanding under the note, amounting to $189, into 1,016,109 shares of Common Stock.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On December 13, 2009, the Company issued a $135 Convertible Promissory Note to it legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the note accrued at the rate of 4%. On February 19, 2010, the Company&amp;#8217;s legal advisor converted the entire accrued principal and interest of outstanding under the note into 402,385 shares of Common Stock.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;In May 2010, based on a board resolution dated June 29, 2009 the Company issued to one of its public relations advisors 100,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 143pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On December 16, 2010, the Company issued to a service provider 83,333 shares of the Company's Common Stock. The shares were for public relations services. Related compensation in the amount of $40 is recorded as general and administrative expense.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On December 16, 2010, the Company granted to its Chief Medical Advisor 900,000 shares of the Company's Common Stock for services rendered through December 31 2010. Related compensation in the amount of $180 is recorded as research and development expense (see Note 5B).&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On December 16, 2010 the Company granted to its Chief Scientist 200,000 shares of the Company's Common Stock for services rendered through December 31 2010. Related compensation in the amount of $40 is recorded as research and development expense (see Note 5B).&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;On February 16, 2011 one of the Company's consultants exercised 100,000 warrants to Common Stock for $33.&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-weight: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;On February 18, 2011, the Company's legal advisor converted the entire accrued principal and interest of the Convertible Promissory Note granted on September 15, 2010, totaling $137, into 445,617 shares of Common Stock.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;The total stock-based compensation expense, related to shares, options and warrants granted to employee&amp;#8217;s directors and service providers, was comprised, at each period, as follows:&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 141.75pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left; font-weight: normal;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt
 solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap"&gt;Three&amp;#160;months &lt;br /&gt;ended&amp;#160;March&amp;#160;31&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Period&amp;#160;from &lt;br /&gt;September&amp;#160;22,&amp;#160;2000&amp;#160;&lt;br /&gt;(inception&amp;#160;date)&lt;br /&gt;through&lt;br /&gt;March&amp;#160;31,&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left; font-weight: normal;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;2011&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left; font-weight: normal;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap"&gt;Unaudited&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"&gt;Unaudited&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-weight: normal;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-weight: normal;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-weight: normal;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; width: 55%;"&gt;Research and development&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 12%;"&gt;13&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 12%;"&gt;9&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 12%;"&gt;17,556&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left;"&gt;General and administrative&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;168&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;-2&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;10,281&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #ccffcc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Financial expenses, net&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;-&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;248&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt;"&gt;Total stock-based compensation expense&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;181&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;7&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;28,098&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px; font: bold 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0%;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 9&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;SUBSEQUENT EVENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;In April 2012, the former CEO exercised 1,014,757 options to shares of Common Stock of the Company. An exercise fee of $112 was paid to the Company. (See note 8 B 2 (a))&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 85.5pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;In April 2012, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. (See note 8 B 2 (a))&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0.5in 0pt 0px; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: top;"&gt;
&lt;td style="width: 58.5pt;"&gt;&lt;/td&gt;
&lt;td style="width: 27pt;"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;In April 2012, the Company granted to Hadasit a warrant to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. (See note 8 B 2 (a))&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin: 0px;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<bcli:ShortTermConvertibleLoansTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="width: 0%;"&gt;&lt;/td&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE 7&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;SHORT-TERM LOANS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;In March 2007, the Company issued a $150 convertible note to a lender, with an annual interest rate of 8% for the first year, with an increase up to 10% after the first year. On January 27, 2010, the lender converted the entire accrued principal and interest of $189 into 1,016,109 shares of Common Stock of the Company. In July 2011, the Company issued to the lender an additional 309,977 shares of Common Stock of the Company with regard to the above conversion.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;Since the outcome of the issuance of the shares was to relieve the debtor from its obligation, based on guidance in ASC 860-10 (formerly FASB No 140) and ASC 450-20 Extinguishment of Liabilities&amp;#8221; the Company derecognized the liability with the difference recognized in earnings.&lt;/p&gt;
&lt;p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</bcli:ShortTermConvertibleLoansTextBlock>
	<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_31-Dec-2011" unitRef="USD" xsi:nil="true"/>
	<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of_31-Mar-2012" unitRef="USD" xsi:nil="true"/>
	<us-gaap:QuarterlyFinancialInformationTextBlock contextRef="Context_3ME_31-Mar-2012">&lt;table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 56.7pt;"&gt;NOTE&amp;#160;3&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/td&gt;
&lt;td style="text-align: justify;"&gt;UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;The accompanying unaudited interim financial statements have been prepared in a condensed format and include the consolidated financial operations of the Company and its wholly-owned subsidiary as of March 31, 2012 and for the three months then ended, in accordance with accounting principles generally accepted in the United States relating to the preparation of financial statements for interim periods. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for the year ended December 31, 2012.&lt;/p&gt;
&lt;p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
	<bcli:ConversionOfDebtToTradePayableToCommonStock contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">84000</bcli:ConversionOfDebtToTradePayableToCommonStock>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo contextRef="Context_3ME_31-Mar-2011" unitRef="USD" decimals="-3">3357000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="-3">1000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3356000</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_DeficitAccumulatedDuringTheDevelopmentStageMember" unitRef="USD" decimals="-3">0</bcli:StockIssuedDuringPeriodForPrivatePlacementValueIssuesTwo>
	<bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesTwo contextRef="Context_3ME_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="Shares" decimals="0">13327600</bcli:StockIssuedDuringPeriodForPrivatePlacementSharesIssuesTwo>
	<!-- Footnote Section -->
	<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type="locator" xlink:href="#Item_1" xlink:label="lab_Item_1"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_1" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_3" xlink:label="lab_Item_3"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_3" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_4" xlink:label="lab_Item_4"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_4" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_6" xlink:label="lab_Item_6"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_6" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_7" xlink:label="lab_Item_7"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_7" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_8" xlink:label="lab_Item_8"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_8" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_9" xlink:label="lab_Item_9"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_9" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_10" xlink:label="lab_Item_10"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_10" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_11" xlink:label="lab_Item_11"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_11" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_12" xlink:label="lab_Item_12"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_12" xlink:to="Footnote_5" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_13" xlink:label="lab_Item_13"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_13" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_14" xlink:label="lab_Item_14"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_14" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_15" xlink:label="lab_Item_15"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_15" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_17" xlink:label="lab_Item_17"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_17" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_18" xlink:label="lab_Item_18"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_18" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_19" xlink:label="lab_Item_19"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_19" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_20" xlink:label="lab_Item_20"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_20" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_21" xlink:label="lab_Item_21"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_21" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_22" xlink:label="lab_Item_22"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_22" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_23" xlink:label="lab_Item_23"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_23" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_24" xlink:label="lab_Item_24"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_24" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_25" xlink:label="lab_Item_25"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_25" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_26" xlink:label="lab_Item_26"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_26" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_27" xlink:label="lab_Item_27"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_27" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_28" xlink:label="lab_Item_28"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_28" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_29" xlink:label="lab_Item_29"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_29" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_30" xlink:label="lab_Item_30"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_30" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_31" xlink:label="lab_Item_31"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_31" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_32" xlink:label="lab_Item_32"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_32" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_33" xlink:label="lab_Item_33"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_33" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_34" xlink:label="lab_Item_34"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_34" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_35" xlink:label="lab_Item_35"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_35" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_36" xlink:label="lab_Item_36"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_36" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_37" xlink:label="lab_Item_37"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_37" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_38" xlink:label="lab_Item_38"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_38" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_39" xlink:label="lab_Item_39"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_39" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_40" xlink:label="lab_Item_40"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_40" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_41" xlink:label="lab_Item_41"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_41" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_42" xlink:label="lab_Item_42"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_42" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_43" xlink:label="lab_Item_43"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_43" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_44" xlink:label="lab_Item_44"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_44" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_45" xlink:label="lab_Item_45"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_45" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_46" xlink:label="lab_Item_46"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_46" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_47" xlink:label="lab_Item_47"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_47" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_48" xlink:label="lab_Item_48"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_48" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_49" xlink:label="lab_Item_49"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_49" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_50" xlink:label="lab_Item_50"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_50" xlink:to="Footnote_16" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_51" xlink:label="lab_Item_51"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_51" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_52" xlink:label="lab_Item_52"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_52" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_53" xlink:label="lab_Item_53"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_53" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_54" xlink:label="lab_Item_54"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_54" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_55" xlink:label="lab_Item_55"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_55" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_56" xlink:label="lab_Item_56"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_56" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_57" xlink:label="lab_Item_57"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_57" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_58" xlink:label="lab_Item_58"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_58" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_59" xlink:label="lab_Item_59"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_59" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_60" xlink:label="lab_Item_60"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_60" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_61" xlink:label="lab_Item_61"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_61" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_62" xlink:label="lab_Item_62"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_62" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_63" xlink:label="lab_Item_63"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_63" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_64" xlink:label="lab_Item_64"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_64" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_65" xlink:label="lab_Item_65"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_65" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_66" xlink:label="lab_Item_66"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_66" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_67" xlink:label="lab_Item_67"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_67" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_68" xlink:label="lab_Item_68"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_68" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_69" xlink:label="lab_Item_69"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_69" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_70" xlink:label="lab_Item_70"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_70" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_71" xlink:label="lab_Item_71"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_71" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_72" xlink:label="lab_Item_72"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_72" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_73" xlink:label="lab_Item_73"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_73" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_74" xlink:label="lab_Item_74"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_74" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_75" xlink:label="lab_Item_75"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_75" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_76" xlink:label="lab_Item_76"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_76" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_77" xlink:label="lab_Item_77"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_77" xlink:to="Footnote_2" order="1.0"/>
		<link:loc xlink:type="locator" xlink:href="#Item_78" xlink:label="lab_Item_78"/>
		<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="lab_Item_78" xlink:to="Footnote_2" order="1.0"/>
		<link:footnote xlink:type="resource" xlink:label="Footnote_2" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Out of the which, cash flows used in discontinued operating activities of $36, cash flows used in discontinued investing activities of $16 and cash flows provided in discontinued financing activities of $57, relating to the period from inception to March 31, 2004, is unaudited.</link:footnote>
		<link:footnote xlink:type="resource" xlink:label="Footnote_5" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.</link:footnote>
		<link:footnote xlink:type="resource" xlink:label="Footnote_16" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Represents an amount less than $1.</link:footnote>
	</link:footnoteLink>
	<xbrli:context id="Context_As_Of_07-May-2012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001137883</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-05-07</xbrli:instant></xbrli:period></xbrli:context>
	<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of_07-May-2012" unitRef="Shares" decimals="0">128586644</dei:EntityCommonStockSharesOutstanding>
</xbrli:xbrl>
